.png){kind=icon}
.png){kind=icon}
Return
Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma model
.png){kind=icon}
OA
AI
DOI：10.1038/s41416-024-02918-x.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En
Journal
IF:
6.8
Papers:
1.7W
Citations:
5.0W